Publication:
Isotretinoin has no negative effect on attention, executive function and mood

Simple item page
dc.contributor.authorÖZAYDIN, AYŞE NİLÜFER
dc.contributor.authorsErgun, T.; Seckin, D.; Ozaydin, N.; Bakar, O.; Comert, A.; Atsu, N.; Demircay, Z.; Yoney, H.; Zaimoglu, S.
dc.date.accessioned2022-03-12T18:06:42Z
dc.date.available2022-03-12T18:06:42Z
dc.date.issued2012
dc.description.abstractBackground According to some animal data, impairments in learning and memory are seen with isotretinoin. Isotretinoin has been shown to affect human brain metabolism, but the data on human neural functions is lacking. Objectives To evaluate whether isotretinoin treatment affects cognitive functions, causes depression and anxiety or alters anger level and anger expression. Methods Neuropsychological tests of attention and executive functions, behavioural tests measuring anger and depression and measures assessing acne severity were applied to 63 severe and / or resistant acne patients from four medical centres including one primary care institute and three university hospitals at the beginning, at the end of first month, third month and at end of treatment with isotretinoin. Results From a total of 63 patients, 15 missed the final visit and 48 were evaluated. Overall, 11 (six women, five men) and five (all women) patients reported anger and depression, respectively, during treatment. Eleven of these 16 patients improved spontaneously. No detrimental effects of isotretinoin treatment on either executive functions or mood were found. Several executive functions and control of anger trait were found to be improved. Clearing of acne was obtained in 94.6% of patients. Limitations Improvement of several measures may be related to learning effect of repeated testing. Investigating brain functions is a complex process and various methods can be used. Conclusion The test battery used in this study, which is commonly used to evaluate mental status both in adults and children, did not show any negative effect of isotretinoin on executive functional parameters in acne patients.
dc.identifier.doi10.1111/j.1468-3083.2011.04089.x
dc.identifier.eissn1468-3083
dc.identifier.issn0926-9959
dc.identifier.pubmed21545542
dc.identifier.urihttps://hdl.handle.net/11424/230940
dc.identifier.wosWOS:000301709900006
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject13-CIS-RETINOIC ACID ALTERS
dc.subjectRETINOIC ACID
dc.subjectACNE PATIENTS
dc.subjectDISABILITY INDEX
dc.subjectDEPRESSION
dc.subjectMEMORY
dc.subjectRATS
dc.subjectMICE
dc.subjectBEHAVIOR
dc.subjectRECEPTOR
dc.titleIsotretinoin has no negative effect on attention, executive function and mood
dc.typearticle
dspace.entity.typePublication
local.avesis.idc9665118-65d8-4205-980d-20a2de03f663
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atPUBMED
local.journal.numberofpages9
oaire.citation.endPage439
oaire.citation.issue4
oaire.citation.startPage431
oaire.citation.titleJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
oaire.citation.volume26
relation.isAuthorOfPublication43643232-9403-4434-b0a2-58cc1a9d9a4b
relation.isAuthorOfPublication.latestForDiscovery43643232-9403-4434-b0a2-58cc1a9d9a4b

Files

Collections

Research Outputs